Pinnacle Associates’s BioNTech BNTX Stock Holding History

Pinnacle Associates’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$248K	Buy	+2,520	New	+$245K	﹤0.01%	856
2022 Q1	–	Sell	-885	Closed	-$228K	–	790
2021 Q4	$228K	Sell	885 -7,427	-89%	-$2.03M	﹤0.01%	735
2021 Q3	$2.27M	Buy	8,312 +2,517	+43%	+$800K	0.04%	321
2021 Q2	$1.3M	Hold	5,795	–	–	0.02%	394
2021 Q1	$633K	Hold	5,795	–	–	0.01%	496
2020 Q4	$472K	Buy	+5,795	New	+$569K	0.01%	527

Other funds holding BNTX

Temasek Holdings Singapore $36.7B AUM 6.83% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

GSK plc London $497M AUM 35.1% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return

Pinnacle Associates's BNTX Position: Q3 2026 in Review

Pinnacle Associates opened a new position in BioNTech (BNTX) in Q3 2026: 2,520 shares worth $248K. The stake represents ﹤0.01% of the portfolio and ranks #856 among its holdings. This is a return to the name: Pinnacle Associates previously reported a position in BNTX as recently as Q4 2021.

Pinnacle Associates first reported a position in BNTX in Q4 2020 and has held it in 6 quarters since. The position peaked at $2.27M in Q3 2021. 113 funds tracked by Wall St. Rank hold BNTX as of Q3 2026.

Pinnacle Associates held 2,520 shares of BioNTech worth $248K as of Q3 2026.
BioNTech was a new Pinnacle Associates position in Q3 2026.
BioNTech made up ﹤0.01% of Pinnacle Associates's portfolio in Q3 2026, its #856 holding.
Pinnacle Associates first reported a position in BioNTech in Q4 2020 and has held it in 6 quarters since.
Pinnacle Associates's BioNTech position peaked at $2.27M in Q3 2021.
113 funds tracked by Wall St. Rank held BioNTech as of Q3 2026.

Based on Pinnacle Associates's 13F filing for Q3 2026, filed 20 Oct 2026.